Cresset Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,242
Closed -$1.34M 1700
2025
Q4
$1.34M Sell
13,242
-1,810
-12% -$145K 0.01% 681
2025
Q3
$823K Buy
15,052
+626
+4% +$31.3K ﹤0.01% 815
2025
Q2
$767K Buy
14,426
+5,710
+66% +$290K ﹤0.01% 763
2025
Q1
$377K Sell
8,716
-18
-0.2% -$912 ﹤0.01% 1209
2024
Q4
$491K Sell
8,734
-2,218
-20% -$138K ﹤0.01% 1092
2024
Q3
$746K Sell
10,952
-2,097
-16% -$118K ﹤0.01% 1314
2024
Q2
$551K Buy
13,049
+1,286
+11% +$70.8K ﹤0.01% 1393
2024
Q1
$812K Sell
11,763
-1,670
-12% -$106K ﹤0.01% 1086
2023
Q4
$994K Buy
13,433
+59
+0.4% +$3.87K 0.01% 896
2023
Q3
$912K Sell
13,374
-2,613
-16% -$222K ﹤0.01% 900
2023
Q2
$1.5M Buy
15,987
+12,725
+390% +$993K ﹤0.01% 755
2023
Q1
$221K Buy
+3,262
New +$210K ﹤0.01% 721
2022
Q3
Sell
-5,340
Closed -$207K 906
2022
Q2
$207K Sell
5,340
-30
-0.6% -$1.6K ﹤0.01% 831
2022
Q1
$375K Sell
5,370
-2,762
-34% -$202K ﹤0.01% 697
2021
Q4
$633K Sell
8,132
-12,693
-61% -$1.12M 0.01% 617
2021
Q3
$1.99M Buy
20,825
+4,961
+31% +$524K 0.03% 236
2021
Q2
$1.97M Buy
15,864
+2,801
+21% +$334K 0.03% 208
2021
Q1
$1.72M Buy
13,063
+6,862
+111% +$939K 0.03% 192
2020
Q4
$822K Buy
+6,201
New +$750K 0.01% 282
2019
Q2
Sell
-558
Closed -$48K 855
2019
Q1
$48K Buy
558
+321
+135% +$27.3K ﹤0.01% 795
2018
Q4
$15K Buy
+237
New +$16.3K ﹤0.01% 768

Other funds holding EXAS

Cresset Asset Management's EXAS Position: Q1 2026 in Review

Cresset Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 13,242 shares — an estimated $1.34M sold.

Cresset Asset Management first reported a position in EXAS in Q4 2018 and held it in 21 quarters. The position peaked at $1.99M in Q3 2021. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Cresset Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Cresset Asset Management sold 13,242 Exact Sciences shares in Q1 2026, an estimated $1.34M.
  • Cresset Asset Management first reported a position in Exact Sciences in Q4 2018 and held it in 21 quarters.
  • Cresset Asset Management's Exact Sciences position peaked at $1.99M in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Cresset Asset Management's 13F filing for Q1 2026, filed 15 May 2026.